Kidney cancer is a type of solid tumor that occurs in the kidney. In the United States, kidney cancer affects one in three people, with lifetime risks of 1.03% (1 in 80) for women and 2.02% (1 in 46) for males.1 According to the American Cancer Society, an estimated 81,800 new cases of kidney cancer will be discovered in 2023 within the country and about 14,890 people will pass away from it.1 Therefore, studying the causes of kidney cancer and identifying molecular targets is important. This may be aided by a better understanding of gene expression and target pathways.